Earth Science Tech, Inc. (ETST) Achieves Highest Sales Revenue Month in February

DORAL, FL, March 13, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields as well as on R&D for certain medical devices, today announces that February 2018 was its highest-ever sales revenue month..

As anticipated, in February the Company achieved its highest monthly sales revenue, with sales of $75,981.02—a 90% revenue increase compared to $39,881.99 in February 2017. This achievement is due to the Company’s new veteran Chief Sales Officer (CSO) and also its revamped CBD line.

March has started strong and is also headed toward being a high revenue month, further contributing to what is predicted to become the Company’s highest revenue fiscal year. Jill Buzan, ETST’s CSO, states, “My first month with the company has been an amazing experience with so much potential. I’m excited to see that we were able to achieve the highest revenue month to date, especially due to product delivery delays and slight errors made from the manufacture. Starting the month of March, with our full inventory and all errors corrected, we’ll be able to truly take Earth Science Tech, Inc. to new heights.”

Company President, Director and COO Nickolas Tabraue adds, “February looked to be our pivotal month, having the honor of having Jill Buzan as our CSO, transitioning Gabriel Aviles to the position of Chief Learning Officer, (CLO), and introducing our newly revamped CBD line. Jill Buzan has brought so much to our company, and with her experience and knowledge Earth Science Tech, Inc. truly looks to stay innovative and be the trusted CBD brand in the industry. Gabriel Aviles has started recording live, one-hour videos from 1 p.m.-2 p.m. Monday through Friday on our YouTube channel, educating individuals on CBD and answering live questions. The videos will then be shared throughout social media. Our new product revamp has been successful despite the manufacturing delays and minor errors due to the increasing product demand, leading us to rush the process. We are currently working on our next batch, improving our formula and providing adequate manufacturing time to eliminate any potential errors and to prevent backorders.”

Mr. Tabraue continues, “Our audit continues to move forward and looks to be finalized within the month of March and will be used to submit our planned Tier II Regulation A+ as well as our planned OTCQB up-listing. The team and I greatly appreciate our stakeholders’ loyalty, trust and support while growing with us. We plan on sharing updates as they progress.”

About Earth Science Tech, Inc. (ETST)

Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more and to buy CBD Hemp Oil, please visit:

About Earth Science Pharmaceutical

Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (sexually transmitted infections and/or diseases). Earth Science Pharmaceutical CEO Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit:

About Cannabis Therapeutics

Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals, as well as other products & solutions. Cannabis Therapeutics’ mission it to help change the health care landscape by introducing its proprietary cannabis-cannabinoid-based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit:

About KannaBidioiD

KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioid is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit:

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.


Contact Data